Corporate News Johnson & Johnson made approach to Intra-Cellular 6 weeks to 2 months ago – report by Contributor since / Followers 2 days ago yuelan Johnson & Johnson (JNJ) made an approach to Intra-Cellular Therapies (NASDAQ:ITCI) about six weeks to two months ago. There was no sale process, CNBC’s David Faber said on Monday. “J&J came,” Faber said. “They were quite serious, and they got a deal done Tags: JNJ Continue Reading Previous Amazon Web Services teams up with General Catalyst to develop AI healthcare toolsNext Eli Lilly to acquire Scorpion for up to $2.5B Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
